Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine dosing after cardiopulmonary bypass guided by heparin-protamine titration
ChiCTR-TRC-09000380Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of protamine and heparin in rheumatic heart disease (RHD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Postoperative bleeding volume and Postoperative transfusion volume. Started Apr 2009; status: completed.
02
Drugs
protamineheparin
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000380.